Restrictive or Liberal Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: 6-Month Mortality in the MINT Trial

Affiliations

• ¹ Sorbonne Université, Assistance Publique-Hôpitaux de Paris (APHP), Department of Clinical Pharmacology and Department of Clinical Research Platform of East of Paris, French Alliance for Cardiovascular Trials (FACT) (T.S.).
• ² Department of Epidemiology, University of Pittsburgh, PA (B.M.H., M.M.B., M.B.).
• ³ St. Michael's Hospital, Unity Health and Peter Munk Cardiac Centre, University Health Network, University of Toronto, ON, Canada (S.G.G.).
• ⁴ Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada (S.G.G.).
• ⁵ Duke Clinical Research Institute, Duke University, Durham, NC (J.H.A., R.D.L.).
• ⁶ Université Paris-Cité, Assistance Publique-Hôpitaux de Paris, FACT, INSERM U1148, France (P.G.S.).
• ⁷ Brazilian Clinical Research Institute, São Paulo (R.D.L.).
• ⁸ University of Louisville, KY (S.G.).
• ⁹ University Hospital of Poitiers, Clinical Investigation Center (INSERM 1402), Cardiology Department, French Alliance for Cardiovascular Trials (FACT), France (C.B.).
• ¹⁰ Department of Cardiology, Westchester Medical Center, Valhalla, NY (H.A.C.).
• ¹¹ Lancaster General Health, PA (E.L.M.).
• ¹² Mazankowski Alberta Heart Institute, University of Alberta Hospital, Edmonton, Canada (K.R.B.).
• ¹³ Henry Ford Health, Michigan State University College of Human Medicine, Detroit (H.D.A.).
• ¹⁴ Rhode Island Hospital, Providence (J.D.A.).
• ¹⁵ Green Lane Coordinating Center, Auckland, New Zealand (C.A.).
• ¹⁶ Ottawa Hospital Research Institute, ON, Canada (D.A.F.).
• ¹⁷ Baystate Medical Center and University of Massachusetts-Baystate, Springfield (A.M.G.).
• ¹⁸ Bruyere Research Institute, University of Ottawa, ON, Canada (P.C.H.).
• ¹⁹ Centre de recherche du Centre hospitalier de l'Université de Montréal, QB, Canada (P.C.H.).
• ²⁰ Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.L.C.).